BioLineRx
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $5,393 | $6,855 | $6,855 | $0 |
Gross Profit | 4,251 | 5,400 | 5,400 | -221 |
EBITDA | -5,046 | 1,130 | -14,965 | |
EBIT | -5,773 | 484 | -15,186 | |
Net Income | 484 | -696 | -696 | -16,023 |
Net Change In Cash | 5,393 | 6,855 | 6,855 | 0 |
Free Cash Flow | -11,355 | -14,141 | -14,141 | -9,928 |
Cash | 9,623 | 5,990 | 5,990 | 7,727 |
Basic Shares | 79,838 | 1,086,589 | 72,439 | 61,937 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $4,800 | $0 | $0 | $0 |
Gross Profit | 174 | -654 | -702 | -934 |
EBITDA | -41,607 | -22,139 | -23,431 | -22,338 |
EBIT | -42,991 | -22,793 | -24,133 | -23,272 |
Net Income | -60,614 | -18,872 | -28,144 | -30,932 |
Net Change In Cash | 4,800 | 0 | 0 | 0 |
Free Cash Flow | -22,905 | -26,556 | -23,670 | -23,206 |
Cash | 4,255 | 10,587 | 12,990 | 16,831 |
Basic Shares | 64,224 | 51,597 | 44,195 | 16,856 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | $0.006 |
2024-03-31 | -$0.01 |
2023-12-31 | -$0.15 |
2023-09-30 | -$0.01 |
